Live Breaking News & Updates on David Lebwohl

Stay updated with breaking news from David lebwohl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intellia Therapeutics (NASDAQ:NTLA) Shares Up 11.3%

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […] ....

Johnm Leonard , David Lebwohl , Morgan Stanley , Group Wealth Management , Penserra Capital Management , Intellia Therapeutics Inc , Blue Trust Inc , Canaccord Genuity Group , Securities Exchange Commission , Intellia Therapeutics Company Profile , Goldman Sachs Group , Intellia Therapeutics , Get Free Report , Genuity Group , Exchange Commission , Investment Management , Capital Management , Wealth Management , Intellia Therapeutics Daily ,

Intellia Therapeutics (NASDAQ:NTLA) Announces Quarterly Earnings Results

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.01, Briefing.com reports. The business had revenue of ($1.92) million during the quarter, compared to analyst estimates of $15.10 million. Intellia Therapeutics had a negative return on […] ....

Hong Kong , Laura Sepp Lorenzino , Raymond James , David Lebwohl , Securities Exchange Commission , Hong Kong Ltd , Wealth Management , Life Insurance Co , Royal Bank , Intellia Therapeutics Company Profile , Tower Research Capital , Financial Services Group Inc , Canaccord Genuity Group , Intellia Therapeutics Inc , Wolfe Research , Intellia Therapeutics , Get Free Report , Exchange Commission , Kong Ltd , Services Group , Research Capital , Intellia Therapeutics Daily , Nasdaq Ntla ,

Intellia Therapeutics (NASDAQ:NTLA) Releases Earnings Results, Beats Expectations By $0.01 EPS

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […] ....

Nova Scotia , David Lebwohl , Johnm Leonard , Vanguard Group Inc , Intellia Therapeutics Inc , Royal Bank , Morgan Stanley , Blackrock Inc , Pricet Rowe Associates Inc , Securities Exchange Commission , Intellia Therapeutics , Get Free Report , Therapeutics Stock Down , Exchange Commission , Street Corp , Pricet Rowe Associates , Intellia Therapeutics Daily , Nasdaq Ntla ,